Jacquelyn Maher, MD
Professor
Medicine
School of Medicine

Dr. Maher is Chief of the Division of Gastroenterology at San Francisco General Hospital and Director of the UCSF Liver Center. Research in her laboratory focuses on the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Her studies in mice have implicated dietary sugar as an important inducer of fatty liver disease, through conversion to toxic saturated fatty acids.

Show full bio (80 words) Hide full bio

Ongoing work in her group concentrates on the mechanism by which metabolic stresses kill liver cells. She is also using induced pluripotent stem cells (iPSCs) from patients with NAFLD to study the disorder directly in humans. Her research team has recently found that NAFLD iPSCs, when converted in the laboratory to hepatocytes (iPSC-Heps), display characteristics of NAFLD. The group is currently expanding their work with NAFLD iPSC-Heps to encompass larger populations from a variety of ethnic backgrounds.

Education & Training

Show all (4) Hide

  • Fellowship Gastroenterology University of California, San Francisco 1987
  • Residency Internal Medicine Duke University Medical Center 1983
  • M.D. Duke University School of Medicine 1979
  • B.A Chemistry Duke University 1976

Websites

Show all (1) Hide

Grants and Projects

Show all (3) Hide

Publications (100)

Top publication keywords:
Chemokines, CXCChemical and Drug Induced Liver InjuryKupffer CellsHepatitis, AlcoholicLipogenesisCD18 AntigensX-Box Binding Protein 1Fatty LiverEndoribonucleasesHepatocytesMethionineNon-alcoholic Fatty Liver DiseaseHepatitisLiverCholine Deficiency

Show all (95 more) Hide